Biomarck Pharmaceuticals, Ltd. Employee Directory
Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees
Biomarck Pharmaceuticals, Ltd. is a small to mid-sized biotechnology company developing therapies for inflammatory and immunological diseases. It relies on a platform of peptide compounds designed to inhibit MARCKS, a protein involved in inflammatory signaling. By targeting MARCKS, the approach aims to reduce neutrophil accumulation at inflamed sites and curb cytokine release, addressing core drivers of inflammation. Based in Durham, North Carolina, the company operates as a clinical-stage biotechnology company within the pharmaceutical sector, pursuing peptide-based therapies aimed at inflammatory conditions. Its work addresses the needs of patients and clinicians seeking targeted anti-inflammatory options where neutrophil behavior and cytokine activity play a central role. In January 2021, the company announced the appointment of Dr. Graham G. Lumsden as President and Chief Executive Officer, reflecting leadership changes during its ongoing development efforts.
1-888-653-2347 
support@leadiq.com 
